Current data has a 15-minute delay. Please Sign Up /
Sign In to get real-time quotes.
stocks
/
NASDAQ-BTAI
/
B
Bioxcel Therapeutics
BTAI
BTAIBioxcel TherapeuticsNASDAQ
Add to watchlist
--
At close :
Jan 03, 16:00 ET
18.40
0.00(0.00 %)
Post market
20:00 ET
B
Bioxcel Therapeutics
BTAI
(BTAI)
--
--(0.00 %)
Summary
Options
Financials
News
Filings
Profile
BTAI Chart
See on advanced chart >
Volume--
Turnover--
P/E(TTM)--
Turnover %--%
P/E(Static)--
Market Cap--
P/B--
Shares--
52 Week Range
--
--
Day Range
--
--
About
Bioxcel Therapeutics, Inc. became a Delaware Corporation and a wholly owned subsidiary of BioXcel on March 29, 2017. BioXcel Therapeutics, Inc., or BTI, is a clinical-stage biopharmaceutical company focused on drug development that uses novel artificial...
Read More
Highlight
A biopharmaceutical company developing novel therapeutics for neuroscience and immuno-oncology disorders